UnitedHealth Plunges, Lilly Gains on Weight-Loss Pill, Trump Slams Powell 4/17/25

Wrapping up a volatile holiday-shortened trading week, Carl Quintanilla, Jim Cramer and David Faber delved into two big movers: UnitedHealth plunging and dragging the Dow into sell-off mode after posting an earnings miss and slashing guidance due to higher medical care costs. A different story for Eli Lilly -- shares surging in reaction to late-stage trial results involving its experimental obesity pill. The anchors reacted to President Trump's Truth Social post blasting Jerome Powell -- it says the Fed chair's "termination cannot come fast enough." Also in focus: Nvidia CEO Jensen Huang visits China and Taiwan Semiconductor beats on earnings after Wednesday's chip sector sell-off, "Faber Report on" Global Payments' $22.7 billion acquisition. Squawk on the Street Disclaimer